Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis

The number of elderly hepatocellular carcinoma (HCC) patients is expected to rise. We analyzed the impact of age on clinical presentations, treatment allocation, and long-term survival between elderly (≥75 years) and younger (<75 years) HCC patients. In this study, a total of 812 elderly and 2270...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603105/
https://www.ncbi.nlm.nih.gov/pubmed/25526453
http://dx.doi.org/10.1097/MD.0000000000000264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603105/
https://www.ncbi.nlm.nih.gov/pubmed/25526453
http://dx.doi.org/10.1097/MD.0000000000000264

Ejemplares similares